Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nor Aina E"'
Autor:
Noor Mastura Mohd Mujar, Maznah Dahlui, Nor Aina Emran, Imisairi Abdul Hadi, Yang Wai Yan, Sarojah Arulanantham, Chan Hooi Chea, Nur Aishah Mohd Taib
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEThe aim of this study is to determine the pathway that women follow for Breast Cancer Care (BCC) and the time intervals from symptom discovery to treatment initiation and to develop a quality matrix framework.METHODSA retrospective cohort stud
Externí odkaz:
https://doaj.org/article/50107b3ae09f4cb9b82e0e242a5c348d
Autor:
Raevathi Omasanggar, Choo Yee Yu, Geik Yong Ang, Nor Aina Emran, Normayah Kitan, Anita Baghawi, Atiki Falparado Ahmad, Maizaton Atmadini Abdullah, Lay Kek Teh, Sandra Maniam
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233461 (2020)
Cancer development has been ascribed with diverse genetic variations which are identified in both mitochondrial and nuclear genomes. Mitochondrial DNA (mtDNA) alterations have been detected in several tumours which include lung, colorectal, renal, pa
Externí odkaz:
https://doaj.org/article/3577a13356314a4797b724ed20825ae9
Autor:
Noor Mastura Mohd Mujar, Maznah Dahlui, Nor Aina Emran, Imisairi Abdul Hadi, Yan Yang Wai, Sarojah Arulanantham, Chea Chan Hooi, Nur Aishah Mohd Taib
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0176394 (2017)
Complementary and alternative medicine (CAM) is widely used among the breast cancer patients in Malaysia. Delays in presentation, diagnosis and treatment have been shown to impact the disease prognosis. There is considerable use of CAM amongst breast
Externí odkaz:
https://doaj.org/article/966cf78a743e4ab2b51967a6911f2a28
Low prevalence of CHEK2 gene mutations in multiethnic cohorts of breast cancer patients in Malaysia.
Autor:
Suriati Mohamad, Nurismah Md Isa, Rohaizak Muhammad, Nor Aina Emran, Nor Mayah Kitan, Peter Kang, In Nee Kang, Nur Aishah Mohd Taib, Soo Hwang Teo, Sharifah Noor Akmal
Publikováno v:
PLoS ONE, Vol 10, Iss 1, p e0117104 (2015)
CHEK2 is a protein kinase that is involved in cell-cycle checkpoint control after DNA damage. Germline mutations in CHEK2 gene have been associated with increase in breast cancer risk. The aim of this study is to identify the CHEK2 gene germline muta
Externí odkaz:
https://doaj.org/article/e7a8cd26331a4830825d2d78bba5c58b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lim SY; Universiti Putra Malaysia, Faculty of Medicine and Health Sciences, Department of Surgery, Serdang, 43400 Selangor, Malaysia. 2705xy@gmail.com., Jee SL; Hospital Kuala Lumpur, Department of Surgery, Breast and Endocrine Unit, Kuala Lumpur, Malaysia., Gee T; Universiti Putra Malaysia, Faculty of Medicine and Health Sciences, Department of Surgery, Serdang, 43400 Selangor, Malaysia., Nor Aina E; Hospital Kuala Lumpur, Department of Surgery, Breast and Endocrine Unit, Kuala Lumpur, Malaysia.
Publikováno v:
The Medical journal of Malaysia [Med J Malaysia] 2016 Dec; Vol. 71 (6), pp. 370-371.
Autor:
Nor Aina E; Breast and Endocrine Surgical Unit, Department of Surgery, Hospital Kuala Lumpur, Jalan Pahang, 50586 Kuala Lumpur, Malaysia.
Publikováno v:
The Medical journal of Malaysia [Med J Malaysia] 2008 Sep; Vol. 63 Suppl C, pp. 72-3.